Friday April 25, 2003
DEPO-PROVERA LEADS TO 100 TIMES GREATER HERPES SUSCEPTABILITY
HAMILTON, ON, April 25, 2003 (LifeSiteNews.com) - Researchers at McMaster University have found that the abortifacient injectable birth-control drug Depo-Provera caused mice to be 100 times more susceptible to infection with herpes simplex virus type 2 (HSV-2).
The study, published in the current issue of the Journal of Virology (2003;77:4558-4565), also found that the mice injected with the drug had a significantly weaker immune response when exposed to the virus.
While spokesman for Pfizer, the pharmaceutical which manufactures Depo-Provera, were quick to condemn the study, the researchers noted that the study merely confirmed former research noting the drug increased risk of STDs.
See the Reuters coverage:
http://asia.reuters.com/newsArticle.jhtml?type=healthNews&storyID=2624281
Latest Headlines
- BREAKING: US Congress Passes Health Care Reform Bill 220 to 215

- Stupak Amendment to Health Care Bill Passes 240 - 194 Saturday Evening

- Major Health Care Development - Pro-Life Stupak Amendment Vote OK'd for Today

- NY Times: Dems Banking on Later Squeezing Pro-Life Language Out of Bill in Committee

- USCCB Spokesman: "Definitely Not True" that Bishops Support Bill As it Stands

- TIME Got it Wrong - Prof. George Opposed Grandiose Kennedy Funeral

- USCCB Condemnation Tears Facade off "Phony" Abortion Compromise for Health Bill

- Health Care Bill Includes Monthly Abortion Premium: House Minority Leader Boehner

- TIME Article Setting Burke Against O'Malley Called "Tactical strike" on Behalf of Catholic Left

- Dirty Fighting on Abortion Funding: Word-Games and Health-Care Theatrics Boggle the Mind

- Commentary on November 6 News

- Note to LifeSiteNews Subscribers with Rogers email addresses

- New York Gov. Declares Nov. 10 Extraordinary Legislative Session for Same-Sex "Marriage"

- Washington's Pro-Family Amendment Effort Defeated - R-71 Almost Certain to Pass

- Vote Pushed Back on Canadian Euthanasia and Assisted Suicide Bill to Dec. 2

- Elderly U.K. Couple in Good Health Commit Suicide, Complain of Assisted Suicide Law

- Texas Late-Term Abortionist and Baptist Minister Admits: "Am I killing? Yes, I am"

- New Evidence Contradicts CCHD's Findings on Accused Pro-Abortion Partner

- Quebec Priest Denies Possibility of Sexual Reorientation Therapy on TV

- New Hampshire Same-Sex "Marriage" Law in Crosshairs after Maine's Law Crumbles

- Brooklyn Bishop Criticized for Recorded Message Praising Pro-Abortion Politician

- First Group of "Traditionalist" Anglicans in Britain Votes to Enter Catholic Church

Most Read this Week
- Planned Parenthood Director Resigns after Watching Ultrasound of Abortion Procedure
- Breaking: Dominican Community Apologizes for Nun Caught Acting as Abortion Escort
- Nun Defiant Following Rebuke, but Stops Abortion Escorting
- Over 200 Christendom College Students Protest Abortion at Planned Parenthood Clinic
- TIME Article Setting Burke Against O'Malley Called "Tactical strike" on Behalf of Catholics Left
- Scottish Gay Rights Activists Found Guilty of Pedophilia Sentenced to Life Imprisonment
- Newly Identified Corporate Supporters of Planned Parenthood Named
- Health Care Bill Includes Monthly Abortion Premium: House Minority Leader Boehner
- Canadian MP Launches Petition to Stop Federal Funding of Planned Parenthood
- Planned Parenthood's President Lashes Out at USCCB
MORE NEWS:
LifeSiteNews.com Home Page
Last 10 Days
Archives
Special Reports
Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.








Back to Top